We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current APH market cap is 183.11M. The company's latest EPS is GBP 0.0017 and P/E is 200.00.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 118.21M | 135.64M | 129.8M | 163.21M | 167.42M |
| Operating Income | 25.55M | 35.63M | 16.62M | 21.58M | 10.57M |
| Net Income | 18.36M | 25.01M | 8.03M | 7.32M | 936k |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 403.61M | 407.64M | 508.85M | 503.49M | 537.41M |
| Total Liabilities | 151.41M | 133.46M | 227.9M | 221M | 249.75M |
| Total Equity | 252.2M | 274.18M | 280.96M | 282.49M | 287.66M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | 22.17M | 35.76M | 41.57M | 38.66M | 20.97M |
| Investing | -59.08M | -3.28M | -85.86M | -4.6M | -17.03M |
| Financing | 36.59M | -25.2M | 55.75M | -34.34M | -876k |
| Market Cap | 183.11M |
| Price to Earnings Ratio | 200.00 |
| Price to Sales Ratio | 1.1 |
| Price to Cash Ratio | 5.79 |
| Price to Book Ratio | 0.64 |
| Dividend Yield | 5.24% |
| Shares Outstanding | 540.15M |
| Average Volume (1 week) | 1.29M |
| Average Volume (1 Month) | 1.82M |
| 52 Week Change | -42.54% |
| 52 Week High | 60.70 |
| 52 Week Low | 24.55 |
| Spread (Intraday) | 0.45 (1.32%) |
| Company Name | Alliance Pharma Plc |
| Address |
avonbridge house wiltshire SN15 2BB |
| Website | https://www.alliancepharmaceuticals.com |
| Industry | diversified investment holding (D13) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
